Erni Damayanti, Hasbi Hasbi, Sudirman Baco, Eka Mulyawati Kaiin, Andi Mujnisa, and Kusumandari Indah Prahesti conducted the experiments and collected the literature
However, going too long without eating may lead to irritability
In the SURMOUNT-1 trial of tirzepatide, participants on the 15 milligram dose lost an average of 20.9 percent of their body weight over 72 weeks, while the STEP 1 trial of once-weekly semaglutide reported about 14.9 percent over 68 weeks
To view or add a comment, sign in More Relevant Posts As GLP1 therapies move beyond diabetes and obesity, employers face a steady stream of new clinical indications and coverage questions
Many patients experience improvement as their bodies adapt to the medication, though this adaptation may take longer than 8 weeks, particularly during Wegovy's 16-week titration period
Semaglutide Vs Tirzepatide: what are the difference